Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01531881 · ClinicalTrials.gov registry record
Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression
A clinical trial, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- 240
- Enrollment target
NCT01531881 is a clinical trial that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 240 participants.
The verdict
NCT01531881 has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
This research may help dentists or surgeons to better detect areas in the mouth that are either prone to cancer or are early cancers. The earlier the detection on cancer in the mouth, the better the chance that treatment or prevention can be more effective.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2006-03 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01531881
The ClinicalTrials.gov registry entry for NCT01531881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01531881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01531881 about?
NCT01531881 is a clinical study titled "Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression". This research may help dentists or surgeons to better detect areas in the mouth that are either prone to cancer or are early cancers. The earlier the detection on cancer in the mouth, the better the chance that treatment or prevention can be more effective.
What is the current status of trial NCT01531881?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2006-03. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01531881?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.